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ABSTRACT:  Congenital cataract-microcornea syndrome (CCMC) is a clinically and genetically 
heterogeneous condition characterized by lens opacities and microcornea. It appears as a distinct 
phenotype of heritable congenital cataract. Here we report a large Chinese family with autosomal 
dominant congenital cataract and microcornea. Evidence for linkage was detected at marker 
D22S1167 (LOD score [Z]=4.49, recombination fraction [θ]=0.0), which closely flanks the β-
crystallin gene cluster locus. Direct sequencing of the candidate βB1-crystallin gene (CRYBB1) 
revealed a c.387C>A transversion in exon 4, which cosegregated with the disease in the family and 
resulted in the substitution of serine by arginine at codon 129 (p.Ser129Arg). A comparison of the 
biophysical properties of the recombinant β-crystallins revealed that the mutation impaired the 
structures of both βB1-crystallin homomer and βB1/βA3-crystallin heteromer. More importantly, 
the mutation significantly decreased the thermal stability of βB1/βA3-crystallin but not βB1-
crystallin. These findings highlight the importance of protein-protein interactions among β-
crystallins in maintaining lens transparency, and provide a novel insight into the molecular 
mechanism underlying the pathogenesis of human CCMC. ©2010 Wiley-Liss, Inc. 
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INTRODUCTION 
 
Congenital cataract is a clinically and genetically heterogeneous group of eye disorders that accounts for one-
tenth of the cases of childhood blindness (Gilbert, et al., 1993). Its prevalence is estimated to vary from 0.6 to 6 per 
10,000 live births (Reddy, et al., 2004). Congenital cataract tends to be inherited in a Mendelian mode, and can be 
isolated or occur in association with other ocular or systemic diseases. Congenital cataract-microcornea syndrome 
(CCMC; MIM# 116150) appears as a distinct phenotype affecting 12%-18% of heritable congenital cataract cases 
(Hansen, et al., 2007), and characterized by lens opacity and a corneal diameter smaller than 11 mm (Easty, et al., 
1999). Genetically, CCMC is a heterogeneous condition. To date, up to eight genes have been reported in 
autosomal dominant CCMC (Kloeckener-Gruissem, et al., 2008; Abouzeid, et al., 2009; Zhang, et al., 2009; Zhou,   
et al., 2010), including five crystallin genes (namely αA-crystallin (CRYAA),  βA4-crystallin(CRYBA4),  βB1-
crystallin (CRYBB1), γC-crystallin (CRYGC) and γD-crystallin (CRYGD)), connexin 50 gene(GJA8), basic leucine 
zipper transcriptional factor (MAF), and solute carrier, SCL16A12 (a carboxylic acid transporter). However, the 
molecular mechanisms of CCMC caused by these gene mutations are still unclear. Functional analysis of mutant 
gene product is needed to disclose the underlying pathogenesis of CCMC. 
In this study, we identified a novel missense mutation, p.Ser129Arg, in exon 4 of CRYBB1 (MIM# 600929) in a 
Chinese family with automomal dominant CCMC. Biophysical studies of the recombinant β-crystallins revealed 
that this mutation resulted in an alteration of the structures of both βB1-crystallin homomer and βB1/βA3-
crystallin heteromer. The structural modification led to a significant decrease in the ability of βB1-crystallin to 
protect βA3-crystallin in the heteromers against aggregation induced by heat. To our knowledge, this is the first 
mutation in exon 4 of CRYBB1 found to be disease-causing for CCMC, and is the first identified mutation that lead 
to the destabilization of proteins by interfering β-crystallin interactions. 
 
MATERIALS AND METHODS 
 
Clinical assessment 
This study adhered to the tenets of the Declaration of Helsinki and was approved by the ethics committees for 
medical research at Capital Medical University. A five-generation family with congenital cataract and 
microcornea, originating from Hebei province, was recruited at Beijing Tongren Eye Center, Beijing Tongren 
Hospital (Capital Medical University, Beijing, China). A total of 23 family members (9 affected and 14 
unaffected) participated in this study and had a full ocular assessment to document the phenotype, including visual 
acuity testing, slit-lamp photography, corneal diameter measurement, and axial length measurement using A-scan 
ultrasonography. Following informed consent, peripheral venous blood was collected for genomic DNA extraction 
using QIAamp DNA kit (Qiagen, Valencia, CA).   
 
Linkage analysis 
Genotyping and allele sharing exclusion analysis was performed as described by Gu et al previously (Gu, et al., 
2008). Haplotypes were generated using the program Cyrillic 2.1. A two-point linkage was calculated with the 
Linkage package (version 5.2). The cataracts in this family were analyzed as an autosomal dominant trait with full 
penetrance and a gene frequency of 0.0001. The allele frequencies for each marker were assumed to be equal in 
both genders. The marker order and distances between the markers were taken from the UCSC database 
(http://genome.ucsc.edu). 
 
Mutation and bioinformatics analysis 
Nucleotide numbering reflects cDNA numbering with +1 corresponding to the A of the ATG translation 
initiation codon in the reference sequence, according to journal guidelines (www.hgvs.org/mutnomen). The 
initiation codon is codon 1. Mutation analysis of CRYBB1 (RefSeq NM_001887.3), CRYBB2 (RefSeq 
NM_000496.2),  CRYBB3  (RefSeq NM_004076.3), and CRYBA4  (RefSeq NM_001886.2) was undertaken by E2052  Wang et al. 
direct sequencing using primers and the protocol described previously (Wang, et al., 2007). The possible 
functional impact of an amino acid change was predicted by the PolyPhen program 
(http://genetics.bwh.harvard.edu/pph/). 
 
Plasmid constructs and site-directed mutagenesis   
Human lenses total cDNA was obtained using the standard methods as described previously (Gu, et al., 2008). 
The coding sequences of human βB1- and βA3-crystallin were isolated from the human lens cDNA library by 
PCR using the following primers: βB1-crystallin (F: CGGGATCCATGTCTCAGGCTGCAAAGGC, R: 
CCAAGCTTTCACTTGGGG GGCTCTGTGG), βA3-crystallin (F: AAGGATCCATGGAGACCCAGGCTGA, 
R: GGAAGCTTCTACTGTTGGATTCGGCGAA). The PCR product was cloned in T-simple vector (Takara 
Corp.) and sequenced. The insert was then cloned in pET28a for protein expression. The sense and anti-sense 
primers for the construction of the S129R mutant of βB1-crystallin were ACACATGGTCGAGAAGCTACCGCA 
and TGCGGTAGCTTCTCGACCATGTGT, respectively. 
 
Protein expression and purification 
Details regarding the overexpression and purification of the recombinant proteins were similar to those 
described previously (Pang, et al., 2010) with some modifications. In brief, the expression constructs were 
transformed into E. coli strain BL21 (DE3). The six-His Tag sequence of pET28a vector was fused to the N-
terminus of the genes to facilitate further purification. The overexpression of the proteins was induced by the 
addition of 0.1 mM IPTG when the cell cultures reached an OD value of 0.6-0.8. After shaking for another 4 h, the 
cells were harvested, resuspended in buffer A (20 mM sodium phosphate, 0.5 M NaCl, 1% PMSF) and lysed by 
sonication in ice bath. The soluble fraction was separated by centrifugation at 8000 × g for 30 min at 4°C. The 
recombinant proteins containing six His tags at the N-terminus were purified by an affinity chromatographic 
method using the Ni
2+ chelating column. The matrix-bound protein was eluted with buffer A containing 250 mM 
imidazole (pH 7.4), and then purified by gel filtration chromatography using a Superdex 200 HR 10/30 column in 
buffer B (20 mM sodium phosphate, 0.15 M NaCl, 1 mM DTT, 1 mM EDTA). The protein concentration was 
determined according to the Bradford method using bovine serum albumin as a standard (Bradford, 1976). Since 
the proteins were prone to be degraded at the N-terminus after storage at 4°C for several days, all protein samples 
were freshly prepared for further biophysical research. 
 
Biophysical characterization of the recombinant proteins 
The βB1/βA3-crystallin heteromer was prepared by incubating equimolar of βB1-crystallin and βA3-crystallin 
at 37°C for 2 h, and the formation of heteromer was identified by size-exclusion chromatography (SEC) and SDS-
PAGE analysis. The effect of the mutation on the structures of both βB1-crystallin homomer and βB1/βA3-
crystallin heteromer was evaluated by far-UV circular dichroism (CD), intrinsic and extrinsic ANS fluorescence 
and SEC analysis as described previously (Pang, et al., 2010). In brief, the far-UV CD was measured on a Jasco-
715 spectrophotometer using 0.1-cm-pathlength cells. The fluorescence emission spectra were recorded on a 
Hitachi F-2500 spectrofluorimeter using 1-cm-pathlength cuvettes. The intrinsic fluorescence was measured using 
an excitation wavelength of 280 nm, while the ANS fluorescence was obtained by excitation at 380 nm. All 
spectroscopic experiments were performed at 25°C. The samples were prepared in buffer B with a protein 
concentration of 0.2 mg/ml.   
As for the SEC analysis, 100 μl samples were injected into an analytical grade 24 ml Superdex 75 HR 10/30 
column equilibrated in buffer B on an ÄKTA purification system with a flow rate of 0.5 ml/min at 4°C. Every 0.5 
ml fractions were collected and analyzed by SDS-PAGE. 
 
Protein stability 
Protein thermal aggregation was used to reflect the effect of the mutation on the stability of both βB1-crystallin 
homomer and βB1/βA3-crystallin heteromer. The aggregation was initiated by incubating the protein samples at  
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60°C. The aggregation of the proteins was monitored by turbidity (absorbance at 400 nm) as a function of time on 
an Ultraspec 4300 pro UV/Visible spectrophotometer. The final protein concentration was 0.2 mg/ml.  The 
aggregation kinetics was analyzed by considering the protein aggregation process as a first order reaction, and the 
following equation could be used for the fitting of the data: 
)) ( exp( 1 ( 0 lim t t k A A − − − =               ( 1 )  
where t is the time of incubation, Alim is the A400 value at the infinite time and k is the rate constant of reaction. 
Data fitting was performed by nonlinear regression analysis using the software Prism, GraphPad Inc. 
 
RESULTS 
 
Clinical features of the family 
We identified a five-generation Chinese family with clear diagnosis of CCMC (Fig 1A). The affected 
individuals presented with bilateral dense nuclear opacities affecting the embryonic and fetal nucleus of the lens 
and average corneal diameter of 10.4 mm. Clinical features of cataract were asymmetric in two eyes of some 
affected individuals. Individual II: 2 presented with dense round nuclear opacities in left eye, while the other 
showed irregular nuclear opacities, which extended from the nucleus to peripheral cortex like a tortoise (Fig. 1B). 
According to the history and medical records, all affected individuals showed cataract within the first year after 
birth and had the similar poor visual acuity, ranging from 0.05 to 0.2 decimal. They also had nystagmus and 
amblyopia. Seven of them underwent cataract extraction before the age of 20 years. There was no family history of 
other ocular or systemic abnormalities. 
Molecular genetic data 
Allele-sharing analysis excluded all the known cataract-related loci except β-crystallin cluster on chromosome 
22q11.2-12.1. Haplotype analysis showed that the affected individuals in the family shared a common haplotype 
between D22S1154 and D22S1144 (Fig. 1A). Linkage analysis gave a maximum two-point LOD score of 4.49 for 
marker D22S1167 at recombination fraction [θ]=0. Mutation analysis of CRYBB1, CRYBB2,  CRYBB3, and 
CRYBA4 in this region showed a single base alteration c.387C>A in the exon 4 of CRYBB1, which caused a 
substitution of serine to arginine at codon 129 (p.Ser129Arg) (Fig. 1C). It was cosegregated with all affected 
individuals in the family, and was not observed in any of the unaffected family members or 100 normal controls. 
The Polyphen score from Polyphen analysis was 1.578, which meant that the p.Ser129Arg CRYBB1 was 
predicted to be “probably damaging”.   
 
Effect of the p.Ser129Arg mutation on the biophysical properties of βB1-crystallin homomer and βB1/βA3-crystallin 
heteromer 
To investigate how the p.Ser129Arg mutation led to CCMC in this large family, the recombinant wild type 
(WT) and mutant His-tagged βB1-crystallins were produced by overexpression in E. coli for further research. 
Under our experimental conditions, most of the recombinant proteins were found to exist in the soluble fraction 
after lysis (data not shown), suggesting that both the WT and mutant proteins could fold efficiently in the 
cytoplasm of the E. coli cells. Since βB1-crystallin has been characterized to exist as homomers or heteromers in 
human lens (Ajaz, et al., 1997; Chan, et al., 2008), the recombinant βA3-crystallin was also purified, and the 
βB1/βA3-crystallin was prepared by incubating equimolar of βB1-crystallin and βA3-crystallin at 37°C for 2 h. 
Similar to previous observations (Dolinska, et al., 2009; Srivastava, et al., 2009), the freshly-prepared recombinant 
proteins mainly existed as a dimer in solutions as identified by static light scattering (data not shown).   
The far-UV CD spectra (Fig. 2A) indicated that the p.Ser129Arg mutation slightly decreased the mean residue 
ellipticity of βB1-crystallin homomer and the βB1/βA3-crystallin heteromer, suggesting that the mutation led to a 
minor decrease in the percentages of the regular secondary structure. No significant changes in the secondary 
structure were observed during the formation of the heteromer for both the WT and mutant βB1-crystallins as 
revealed by the difference CD spectra (the violet lines in Fig. 2A). E2054  Wang et al. 
 
 
 
Figure 1. Mutation analysis of CRYBB1 in a Chinese family with congenital cataract 
and microcornea. (A) Pedigree and haplotype analysis of the family showing the 
segregation of three microsatellite markers on chromosome 22q11.2-12.1. Squares 
and circles indicated males and females, respectively. Blackened symbols and bars 
denoted affected status. The proband was indicated by the arrow. (B) Slit lamp 
photographs of individual II: 2 showing bilateral dense nuclear opacities but 
asymmetric between eyes. (C) DNA sequence chromatograms showed a c.387C>A 
missense mutation of CRYBB1  indicated by an arrow. Mutation was numbered 
according to GenBank NM_001887.3. Nucleotide +1 was A of the ATG initiation 
codon.  
 
 
The WT βB1-crystallin contains 8 Trp and 9 Tyr in each subunit, and among them, Trp124 and Trp127 are 
close to the mutation site. This makes intrinsic fluorescence a powerful tool to monitor the effect of the mutation 
on its tertiary structure. As presented in Fig. 2B, the WT βB1-crystallin had a maximum emission wavelength 
(Emax) of ~334 nm when excited at 280 nm, while a ~1 nm red-shift of the Emax was induced by the mutation. When 
forming heteromer, a blue shift of the Emax was observed, which was quite consistent with previous observations 
(Dolinska, et al., 2009; Srivastava, et al., 2009). The alterations in the tertiary structures of βB1- and βA3-
crystallins could also be identified by the difference spectra (the violet lines in Fig. 2B), and the mutation affected 
the structural transitions during the formation of the heteromer. The effects of the mutation could be more clearly 
characterized by the Parameter A analysis, which is a sensitive tool of reflect the position and shape of the intrinsic 
fluorescence (Su, et al., 2007; Turoverov, et al., 1976). The results in Fig. 2C indicated that the mutation resulted 
in a change in the shape of the intrinsic fluorescence, suggesting that the mutation slightly modified the tertiary 
structure of both βB1-crystallin and βB1/βA3-crystallin to a looser one. This deduction is also consistent with the  
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role of Ser129 by structural analysis. Ser129 is located at the domain and subunit interfaces (Fig. 2F) and forms a 
hydrogen bond with Gly202, but Ser129 is not among the residues that contribute greatly to the stabilization of the 
domain and subunit interfaces (Van Montfort, et al., 2003). No significant changes in the hydrophobic exposure 
were observed as reflected by the almost superimposed ANS fluorescence spectra of the 5 proteins (Fig. 2D), 
which coincides with that Ser129 is on the surface of the dimeric molecule. 
The effect of the p.Ser129Arg mutation on β-crystallin quaternary structure was evaluated by SEC analysis. 
Similar to the previous observations (Dolinska, et al., 2009), the apparent molecular weights of βB1- and βA3-
crystallins identified by SEC were lower than the predicted dimer masses, while that of βB1/βA3-crystallin was 
close to a heterodimer (Fig. 2E). The elution volume of βA3-crystallin was much smaller than that of βB1-
crystallin although the calculated molecular weight of βB1-crystallin is larger than that of βA3-crystallin. This 
observation suggested that the various β-crystallins might have dissimilar shape and/or dimer-monomer 
equilibrium. The distinct position of the heteromer in the SEC profile suggested that SEC could be used to monitor 
the formation of the heteromer by βB1- and βA3-crystallin. The mutant S129R eluted at about 0.8 ml later when 
compared to the WT βB1-crystallin, indicating that the mutant had a relative smaller apparent molecular weight. 
Static light scattering (SLS) experiments was further conducted to identify the oligomeric state of the proteins. The 
SLS data indicated that the WT βB1-crystallin mainly existed in a 68.4 kDa form, while the mutant S129R was 
dominated by a 40.1 kDa form. Thus it seems that the S129R mutation perturbed the dimer interface of βB1-
crystallin and led to a shift to the monomeric state in the dimer-monomer equilibrium. However, in the heteromer, 
the WT and mutant proteins eluted at almost identical volumes. Further analysis of the eluted samples by SDS-
PAGE indicated that the mutation did not affect the ability of βB1-crystallin to form heteromer with βA3-
crystallin. These observations suggested that the mutation altered the dimer-monomer equilibrium of the βB1-
crystallin, but did not significantly influence that of βB1/βA3-crystallin heteromer. 
The p.Ser129Arg mutation destabilizes the structural stability of βB1/βA3-crystallin but not βB1-crystallin 
The above biophysical characterization indicated that the p.Ser129Arg mutation affected the structure of βB1-
crystallin and βB1/βA3-crystallin differentially at the secondary, tertiary and quaternary structure level. To further 
investigate whether the changes in the structural features led to an alteration of protein stability, thermal 
aggregation was used as a model system to reflect the responses of the proteins under stress. The βA3-crystallin 
homomer was prone to aggregate at high temperatures, while both the WT and mutant βB1-crystallin were rather 
stable (Fig. 3A). The aggregation of the mutant was less than that of the WT βB1-crystallin as revealed by an 
about 3-fold decrease of Alim, but did not affect the values of t0 and k (Fig. 3C-3E). Previous studies have shown 
that electrostatic interactions play a crucial role in mediating the process of protein aggregation (Chi, et al., 2003; 
Yan, et al., 2006). Thus the decrease in the amounts of aggregates by the mutation was more like to be caused by 
the substitution of the polar residue Ser by a charged residue Arg at position 129. 
Consistent with previous observations (Srivastava, et al., 2009), the WT βB1-crystallin could efficiently protect 
βA3-crystallin in the heteromer, and the heteromer was even more stable than both homomers as reflected by a 
longer t0 and smaller k (Figs. 3C-3E). All the kinetic parameters indicated that the mutant S129R could partially 
stabilize βA3-crystallin in the heteromer, but the efficiency was much weaker than the WT βB1-crystallin. The 
SDS-PAGE analysis (Fig. 3B) indicated that most of the proteins were presented in the supernatant for the WT 
βB1/βA3-crystallin, while the major component in the aggregates of S129R/βA3-crystallin was βA3-crystallin. 
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Figure 2. Biophysical characterization of the effect of the p.Ser129Arg mutation on the structures of both βB1-crystallin 
homomer and βB1/βA3-crystallin heteromer. The samples were prepared by dissolving the proteins in buffer B. The βB1/βA3-
crystallin was prepared by incubating equimolar of βB1-crystallin and βA3-crystallin at 37°C for 2 h. (A) Far-UV CD. (B) 
Intrinsic fluorescence. In panels (A) and (B), the difference spectra were produced by subtracting the sum spectra of the 
homomers by that of equimolar heteromer. (C) Parameter A. Parameter A was calculated by dividing the fluorescence intensity 
at 320 nm (I320) to that at 365 nm (I365). (D) Extrinsic ANS fluorescence. (E) SEC analysis. The arrow heads along the top axis 
indicate the elution positions of the standard molecular weight markers of 66 kDa, 29 kDa and 14 kDa, from left to right, 
respectively. The inset shows the identification of the heteromer by SDS-PAGE of the eluted samples. M, 1, 2 and 3 represents 
the marker, purified βA3-crystallin, purified βB1-crystallin and the eluted samples of the heteromer collected from the main 
peak in the SEC profile, respectively. The void volume of Superdex 75 HR 10/30 column is 8 ml. (F) Crystal structure of the 
truncated βB1-crystallin (PDB 1OKI) (Van Montfort, et al., 2003). The position of Ser129 was highlighted by the space-filling 
model. 
 
DISCUSSION 
 
In this study, we have identified a novel causative mutation p.Ser129Arg in CRYBB1 in a large Chinese family 
with CCMC. βB1-crystallin is a major subunit of the β-crystallins and comprises 9% of the total soluble crystallin 
in the human lens (Lampi, et al., 1997). The three-dimensional X-ray structure of βB1-crystallin shows it contains 
two tightly folded domains, N-terminal and C-terminal domains, composed of two Greek key motifs(Van 
Montfort, et al., 2003). The mutation detected in this family is located in exon 4, which encodes the Greek key II, 
and replaces the polar uncharged serine by the charged residue arginine at position 129. As suggested by Polyphen 
analysis, the mutation is predicted to be possibly damaging, which highlights the functional importance of this 
region of βB1-crystallin. To our knowledge, this is the first report of causative mutations identified in Greek key II 
of βB1-crystallin associated with CCMC.   
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Figure 3. Effect of the p.Ser129Arg mutation on the thermal stability of βB1-crystallin homomer and βB1/βA3-
crystallin heteromer. (A) The time-course aggregation kinetics monitored by the turbidity at 400 nm at 60°C. The 
raw data was fitted by Eq. 1, and the kinetic parameters were presented in panels (C-E). The decrease of the 
turbidity of βA3-crystallin and S129R/βA3-crystallin after long time incubation was caused by the deposition of the 
large aggregates, and was not included in the curve fitting. (B) SDS-PAGE analysis of the aggregates separated by 
centrifugation. S and P represent supernatant and precipitate, respectively. 
 
 
Apart from the mutation p.Ser129Arg, totally four mutations in CRYBB1 have been reported to cause autosomal 
dominant congenital cataract (ADCC), including p.X253ArgextX27 (Willoughby, et al., 2005), p. Gly220X 
(Mackay, et al., 2002), p.Gln223X (Yang, et al., 2008) and p. Ser228Pro (Wang, et al., 2007). Interestingly, all 
sequence changes reported in these ADCC families are located in exon 6, encoding the Greek key IV and the C-
terminal extension. These mutations might be predicted to result in an abnormally elongated or truncated COOH-
terminus and production of a mutant protein. In addition, clinical phenotypes show some variations among these 
families but all involved nuclear opacifications to a variable extent. Among them, only one mutation 
p.X253ArgextX27 has been associated with inherited cataract and microcornea, predicted to elongate the COOH-
terminal extension. In ADCC, p.Ser129Arg described in this study is the first mutation of CRYBB1 identified not 
in exon 6, which is responsible for bilateral dense nuclear cataract with microcornea and nystagmus in all affected 
members.  
 
The possible molecular mechanism underlying CCMC caused by the p.Ser129Arg mutation was investigated by 
comparing the biophysical properties of the WT and mutant recombinant β-crystallins. Unlike the mutations found 
in the Greek key IV and the C-terminal extension, which resulted in a significant change in the solubility of βB1-
crystallin (Mackay, et al., 2002; Srivastava, et al., 2009), we found that the p.Ser129Arg mutation did not affect 
the folding of recombinant βB1-crystallin in E. coli, implying that this novel mutation might undergo dissimilar 
molecular mechanism with those previously identified ones. Biophysical studies indicated that the mutation 
modified the structure of both βB1-crystallin and βB1/βA3-crystallin, which is consistent with the fact that Ser129 
is close to the domain and subunit interfaces (Fig. 2F) (Van Montfort, et al., 2003). The mutation led to a relatively E2058  Wang et al. 
loose tertiary structure for βB1-crystallin and βB1/βA3-crystallin, but affected their quaternary structure 
differentially. A pronounced effect was observed on the quaternary structure of the homomer, while no significant 
change was observed for the heteromer. This suggested that the formation of heteromer might be able to partially 
rescue the impairment caused by the mutation at the quaternary structure level. It is a pity that the structural basis 
of this effect was unavailable due to the lack of the high-resolution structure of βB1/βA3-crystallin. A possible 
explanation is that the homodimer and heterodimer may share different or have alternative subunit interface/sites, 
as proposed previously (Dolinska, et al., 2009). It seems that the additional sites in the heteromers helped the 
mutant to maintain the correct quaternary structure under physiological conditions. However, the binding interface 
was more likely to be weakened by the mutation, and the heteromer might be prone to dissociate under extreme 
conditions as evidenced by a significant decrease in the stability (Fig. 3). 
Many disease-causing mutations of congenital cataracts have been characterized to destabilize the 
corresponding proteins. Surprisingly, the p.Ser129Arg mutation did not affect the stability of βB1-crystallin, but 
showed a minor extent of beneficial effects on βB1-crystallin thermal stability. Further research indicated that the 
mutation significantly decreased the ability of βB1-crystallin to protect βA3-crystallin against aggregation in the 
heteromer (Fig. 3). βB1-crystallin has long been known to be a crucial protein in forming heteromers with the 
acidic β-crystallins in lens, and the formation of these heteromers are thought to be important to the maintenance 
of transparency of the lens (Ajaz, et al., 1997; Chan, et al., 2008). Thus our results strongly suggested that the 
mutation might result in CMCC via impairing the normal protein interactions and the stability of the heteromers. 
βB1-crystallins is early expressed during mammal lens development and mainly existed in the nucleus (Aarts, et 
al., 1989). The mutation might not only affect the stabilities of the β-crystallins, but also result in severe early 
onset problems in the lens development, which might correlate to the early onset and phenotype of this nuclear 
cataract shown in Fig. 1. Meanwhile, the expression of β-crystallins are also identified in other eye tissues such as 
cornea (Clayton, et al., 1986), and the modified protein interactions caused by the mutation might contribute to the 
development of cornea. 
In summary, we have identified a novel heterozygous p.Ser129Arg mutation in CRYBB1 in a CCMC family of 
Chinese origin. Biophysical studies indicate that the mutation may lead to CCMC by modifying the structure of 
βB1-crystallin and disrupting the normal protein-protein interactions, particularly of the interactions of βB1-
crystallin with the acidic β-crystallins, which further decreases the structural stability of the β-crystallin 
heteromers upon stresses. Identification and characterization of this mutation further confirm the importance of 
protein interactions in maintaining lens transparency, and provide a novel insight into the molecular mechanism 
underlying the pathogenesis of human CCMC.   
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